
OpenAI acquires Orchestra Bio to accelerate drug development with AI
OpenAI acquires Orchestra Bio to integrate AI-powered operations into life sciences R&D, aiming to speed up drug development.
News, trends, and insights from the AI frontier.
Latest AI in life sciences coverage.

OpenAI acquires Orchestra Bio to integrate AI-powered operations into life sciences R&D, aiming to speed up drug development.

Anthropic's Claude achieves 35% hit rate in protein design, outperforming human experts and accelerating drug development.